SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-23-016702
Filing Date
2023-04-05
Accepted
2023-04-05 16:05:31
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-05

Document Format Files

Seq Description Document Type Size
1 ARS brhc10051080_ars.pdf ARS 4860854
  Complete submission text file 0001140361-23-016702.txt   6696469
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35921 | Film No.: 23802511
SIC: 2834 Pharmaceutical Preparations